Back to FIRST MANHATTAN CO. LLC. FIRST MANHATTAN CO. LLC.

BBIOBBIO
10 quarters

Position history for FIRST MANHATTAN CO. LLC.FIRST MANHATTAN CO. LLC.'s holdings in BRIDGEBIO PHARMA INC

FIRST MANHATTAN CO. LLC. previously held 0 shares of BBIO (BRIDGEBIO PHARMA INC), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$24,000

Total Shares Change

-400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$26.37
0
2023-Q2
Unchanged
27,490
0.0%
$472,8280.0%$17.20
0
2023-Q1
Unchanged
27,490
0.0%
$455,7840.0%$16.58
0
2022-Q4
Unchanged
27,490
0.0%
$209,4730.0%$7.62
0
2022-Q3
Decreased
27,490
-68.6%
$273,0000.0%$9.94
0
2022-Q2
New
87,490
-
$794,0000.0%$9.08
34
2021-Q4
Exited
0
-100.0%
$00.0%$16.68
0
2021-Q3
Unchanged
400
0.0%
$18,0000.0%$46.87
0
2021-Q2
Unchanged
400
0.0%
$24,0000.0%$60.96
0
2021-Q1
New
400
-
$24,0000.0%$61.60
26

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used